Evidence map›Paper›PMID 33832608›Full record

ReviewJournal of the American College of Cardiology2021

Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5.

Kathryn J Lindley, C Noel Bairey Merz, Melinda B Davis, Tessa Madden, Ki Park, Natalie A Bello, American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American College of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Peripartum Cardiomyopathy: Risks Diagnosis and Management.Journal of multidisciplinary healthcare · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Kathryn J LindleyCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: Kathryn.lindley@wustl.edu.
C Noel Bairey MerzBarbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, California, USA.
Melinda B DavisDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Tessa MaddenDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA.
Ki ParkCardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.
Natalie A BelloDepartment of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group
Washington University in St. Louis · USCedars-Sinai Smidt Heart Institute · USColumbia University Irving Medical Center · USMichigan Medicine · USUniversity of Florida · US

Funding

Cardiac Manifestations of PreeclampsiaR01HL153382 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BELLO, NATALIE A · 2020 to 2023
$1.6M
Blood Pressure Measurement and Hypertension in PregnancyK23HL136853 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BELLO, NATALIE A · 2018 to 2022
$948k
NHLBI NIH HHS K23 HL136853NHLBI NIH HHS R01 HL153382
6 · The paper itself

Abstract

The majority of reproductive-age women with cardiovascular disease are sexually active. Early and accurate counseling by the cardiovascular team regarding disease-specific contraceptive safety and effectiveness is imperative to preventing unplanned pregnancies in this high-risk group of patients. This document, the final of a 5-part series, provides evidence-based recommendations regarding contraceptive options for women with, or at high risk for, cardiovascular disease as well as recommendations regarding pregnancy termination for women at excessive cardiovascular mortality risk due to pregnancy.

Indexed as

Cardiovascular DiseasesContraceptionFamily Planning ServicesFemaleHumansReproductive HealthRisk Adjustmentabortioncontraceptionintrauterine deviceLARCpregnancy

Identifiers

PMID33832608
PMCPMC8041063
OpenAlexW3140991938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.